Measured, not marketed.
Peacefull is in BETA-1. There are no published outcomes to show. What there is: a public model card, a pre-registered research program in design, and a set of commitments about what we will publish when the evidence comes in — including the numbers that do not move.
Start here.
Model card v0.2.2
What the model is and is not. Training and fine-tuning posture, the six-layer safety evaluation, named failure modes, dependency design commitments, escalation behavior, data and privacy, and the version log. BETA-1. Every change logged.
- Six-layer safety evaluation (incl. bias & equity)
- Ten named failure modes, plus the ones we haven't found yet
- Deterministic escalation path — not model judgment
- FDA Predetermined Change Control Plan structure
The studies in design
Why we publish nothing yet, what we are running, and the commitments each study carries. OBS-90 observational study first, then a hybrid effectiveness-implementation trial, then a micro-randomized trial of specific companion decision points.
- OBS-90 · 90-day observational study (IRB submission in progress)
- Hybrid effectiveness-implementation trial (in design)
- Micro-randomized trial of decision points (months 4–6)
- Pre-registration · intent-to-treat · bias reporting
- Study 01Peacefull-OBS-90IRB submission in progress
90-day observational study
Question. How do patients actually use the companion day-to-day?
Design. Prospective · observational · non-interventional. No randomization, no comparator arm.
- Study 02Hybrid-EIIn design · begins after OBS-90
Effectiveness-implementation trial
Question. Does it help, and can a practice actually run it?
Design. Hybrid type-I. Outcome change (PHQ-9, GAD-7, PROMIS, alliance) + implementation conditions.
- Study 03MRTMonths 4–6 · in design
Micro-randomized trial
Question. Which companion actions, at which moments, move measures?
Design. Within-person randomization at decision-point level. Proximal outcome measurement.
Built on the work that works.
Behavioral Activation.
The between-session scaffolding for depression — activity scheduling, values-linked action, and the small experiments that reconnect mood to behavior.
DBT distress-tolerance skills.
TIPP, radical acceptance, opposite action — the skills a companion can genuinely reinforce in the moment a patient needs them.
Motivational Interviewing.
For ambivalence. Trained against the MI Treatment Integrity code, scored by clinical evaluators, with a trauma-informed stance throughout.
Validated, between-session.
In current scope.
PHQ-9 (depression). GAD-7 (anxiety). Patient-initiated, surfaced to the supervising clinician.
Near-term roadmap.
PROMIS Anxiety and Depression short forms. The WHO-5 Well-Being Index. The Columbia Suicide Severity Rating Scale (C-SSRS) integrated with the deterministic escalation path.
Safety planning.
Where a supervising clinician has scoped it into care, the companion supports co-construction and review of a Stanley-Brown Safety Plan.
Every paper, every framework.
The guidelines, validated instruments, AI governance frameworks, and regulatory guidance the model card references — each with a one-sentence note on how we use it and a link to the canonical source. Twenty-five entries, grouped into seven categories.
Academic partners, reviewers, auditors.
Good-faith replication requests, protocol reviews, independent audits — write to clinical@peacefull-ai.io. Model card concerns — modelcard@peacefull-ai.io. Safety reports from patients, clinicians, educators, or researchers — safety@peacefull-ai.io.